These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24399687)

  • 1. Prostate-specific antigen screening: a critical review of current research and guidelines.
    Robinson JG; Hodges EA; Davison J
    J Am Assoc Nurse Pract; 2014 Oct; 26(10):574-81. PubMed ID: 24399687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for prostate cancer: the current evidence and guidelines controversy.
    Gomella LG; Liu XS; Trabulsi EJ; Kelly WK; Myers R; Showalter T; Dicker A; Wender R
    Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate Cancer Screening and the Associated Controversy.
    Tabayoyong W; Abouassaly R
    Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSA screening: a public health dilemma.
    Mandelson MT; Wagner EH; Thompson RS
    Annu Rev Public Health; 1995; 16():283-306. PubMed ID: 7543756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
    Lim LS; Sherin K;
    Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Japanese guideline for prostate cancer screening.
    Hamashima C; Nakayama T; Sagawa M; Saito H; Sobue T
    Jpn J Clin Oncol; 2009 Jun; 39(6):339-51. PubMed ID: 19346535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline prostate-specific antigen testing at a young age.
    Loeb S; Carter HB; Catalona WJ; Moul JW; Schroder FH
    Eur Urol; 2012 Jan; 61(1):1-7. PubMed ID: 21862205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen screening: friend or foe?
    Linn MM; Ball RA; Maradiegue A
    Urol Nurs; 2007 Dec; 27(6):481-9; quiz 490. PubMed ID: 18217530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on screening for prostate cancer with prostate-specific antigen.
    Schmid HP; Riesen W; Prikler L
    Crit Rev Oncol Hematol; 2004 Apr; 50(1):71-8. PubMed ID: 15094160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practitioner-level determinants of inappropriate prostate-specific antigen screening.
    Kerfoot BP; Holmberg EF; Lawler EV; Krupat E; Conlin PR
    Arch Intern Med; 2007 Jul; 167(13):1367-72. PubMed ID: 17620529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for prostate cancer in asymptomatic men: clinical, legal, and ethical implications.
    Gerard MJ; Frank-Stromborg M
    Oncol Nurs Forum; 1998 Oct; 25(9):1561-9. PubMed ID: 9802052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prostate-specific antigen screening conundrum: examining the evidence.
    O'Rourke ME
    Semin Oncol Nurs; 2011 Nov; 27(4):251-9. PubMed ID: 22018404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for prostate cancer: current recommendations.
    Wilson SS; Crawford ED
    Urol Clin North Am; 2004 May; 31(2):219-26. PubMed ID: 15123402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A literature review of cost-effectiveness analyses of prostate-specific antigen test in prostate cancer screening.
    Garg V; Gu NY; Borrego ME; Raisch DW
    Expert Rev Pharmacoecon Outcomes Res; 2013 Jun; 13(3):327-42. PubMed ID: 23763530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for prostate cancer in New Zealand general practice.
    Zuzana O; Ross L; Fraser H; Charis B; Alistair S; Leanne T; Michael H; Peter G
    J Med Screen; 2013 Mar; 20(1):49-51. PubMed ID: 23612467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSA screening: determinants of primary-care physician practice patterns.
    Tasian GE; Cooperberg MR; Potter MB; Cowan JE; Greene KL; Carroll PR; Chan JM
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):189-94. PubMed ID: 22343837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.
    Cohn JA; Wang CE; Lakeman JC; Silverstein JC; Brendler CB; Novakovic KR; McGuire MS; Helfand BT
    Urol Oncol; 2014 Jan; 32(1):41.e23-30. PubMed ID: 23911680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians.
    Kell JS
    Can J Urol; 2010 Feb; 17 Suppl 1():18-25. PubMed ID: 20170597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer screening: issues and controversies.
    O'Shaughnessy M; Konety B; Warlick C
    Minn Med; 2010 Aug; 93(8):39-44. PubMed ID: 20862878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests?
    Crawford ED; Abrahamsson PA
    Eur Urol; 2008 Aug; 54(2):262-73. PubMed ID: 18556114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.